News
01-23-2014, 12:20 AM
The University of Texas MD Anderson Cancer Center will collaborate with Johnson & Johnson Innovation, LLC, and its affiliate Janssen Biotech, Inc., to develop immunology-based cancer treatments through the MD Anderson Moon Shots Program immunotherapy platform.
More... (http://www.news-medical.net/news/20140123/MD-Anderson-collaborates-with-Johnson-Johnson-to-develop-immunology-based-cancer-treatments.aspx)
More... (http://www.news-medical.net/news/20140123/MD-Anderson-collaborates-with-Johnson-Johnson-to-develop-immunology-based-cancer-treatments.aspx)